Hyong Kim
CIK 1993255 · Chief Medical Officer · last filed 2026-03-19
Hyong Kim is a Chief Medical Officer who has filed 18 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider sold $328.3K of ALHC on Mar 19, 2026. Across all open-market trades the lifetime net is −$5.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.59M
1
18
-$5.64M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALHC | Chief Medical Officer | 367,701 | $20.65 | $7.59M | -$5.64M | 18 | 2026-03-19 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | ALHC | Sell (S) | −18,404 | -$328.3K | EDGAR |
| 2026-03-17 | ALHC | Grant (A) | +52,972 | $0 | EDGAR |
| 2026-01-06 | ALHC | Sell (S) | −16,506 | -$352.4K | EDGAR |
| 2025-12-30 | ALHC | Sell (S) | −12,694 | -$237.9K | EDGAR |
| 2025-10-10 | ALHC | Sell (S) | −85,034 | -$1.48M | EDGAR |
| 2025-08-22 | ALHC | Sell (S) | −24,800 | -$396.8K | EDGAR |
| 2025-08-15 | ALHC | Sell (S) | −18,600 | -$279.6K | EDGAR |
| 2025-08-13 | ALHC | Sell (S) | −18,600 | -$270.4K | EDGAR |
| 2025-03-21 | ALHC | Sell (S) | −26,734 | -$460.3K | EDGAR |
| 2025-03-19 | ALHC | Sell (S) | −8,266 | -$135.6K | EDGAR |